Cite Filings / CRL / 0000902219-25-000211

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed 2025-05-12 Acc 0000902219-25-000211

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-05-15 4 Director sold 140 shares at an average $140.74 ($19,703)
2025-05-15 4 EVP, Corp Strategy & Develop sold 500 shares at $145.41 ($72,705)
2025-05-14 144 Sale of Securities
2025-05-13 144 Sale of Securities
2025-05-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-04-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…